The global DT-based combined vaccines market is anticipated to grow at a significant CAGR of 6.5% during the forecast period 2022-2028. Vaccination seeks to boost the immune system's ability to combat specific antigens. A combined vaccine is designed to protect against two or more diseases or one disease caused by two or more strains or serotypes of the same organism. DT-based combo vaccinations also include antigens such as diphtheria toxoid (D) and tetanus toxoid (T) in addition to other antigens. The rising prevalence of infectious diseases globally are a primary reason driving demand for DT-based combined vaccines.

Furthermore, the advent of combination vaccines suggested for vaccination programmes to lower the number of injections necessary while maintaining immunisation compliance in new-borns is expected to boost the DT-based combined vaccines market. The DT-based combined vaccines protect against three diseases: diphtheria, tetanus, and pertussis. As a result, the decrease of those doses as part of a combination vaccine is projected to provide enormous market growth prospects in the coming years. Infants should receive three doses of DTaP, according to the Centre for Disease Control and Prevention (CDC), to build up high levels of protection against tetanus, whooping cough, and diphtheria.

Impact of COVID-19 on Global DT-Based Combined Vaccines Market

The sudden emergence of the COVID-19 prompted the installation of strict lockdown measures in some countries, causing a substantial decline in the demand of DT-based combined vaccines. As a result, the global DT-based combined vaccines market saw a declining phase. There was an increased threat of the spread of such diseases amongst children which can be prevented by the timely vaccination of DT-based combined vaccines. Although, as soon as the restrictions were lifted, the vaccination started again immediately. However, the gap in vaccines that was caused due to lockdown could not be covered up even after increasing per day vaccination count till the end of 2021. 

Segmental Outlook

The global DT-based combined vaccines market is segmented based on disease type and application. Based on the disease type, the market is sub-segmented into DTaP and DTwP. Based on application, the market is sub-segmented into paediatrics, adults, elderly, and pregnancy. The paediatrics segment holds a major share in the market due to the increased awareness among people regarding proper and timely vaccination of new-borns against infectious disease. Additionally, the paediatric population is more prone to infectious diseases as compared to adults, therefore, proper measures are taken for vaccination. The segments mentioned above can also be customized as per different research requirements.

Global DT-Based Combined Vaccines Market Share by Application, 2021 (%)

The Paediatrics Segment is Anticipated to Hold a Prominent Share in the Global DT-Based Combined Vaccines Market

The paediatrics segment is anticipated to hold the largest share in the market due to rising paediatric population globally. The risk of getting infectious disease is also high amongst paediatric population, thus timely vaccination can prevent them from getting any chronic disease. Due to increased awareness among people, the more clinical visits had also significantly increased for the diagnostic of the infectious diseases. All such, factors will drive the demand for DT-based combined vaccines for paediatric population during the forecast period.

Regional Outlooks

The global DT-Based combined vaccines market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).  The market can also be analyzed for a particular region or country level as per the requirement. 

Global DT-Based Combined Vaccines Market Growth, by Region 2022-2028

The North America Region is Estimated to Hold the Major Share in the Global DT-Based Combined Vaccines Market

The North American region holds major share in the global DT-Based combined vaccines market as it is an early-stage adopter of all the advanced technology developed globally. The region is also enriched with several market players, actively involved in the development of new vaccines for the prevention of harmful diseases. For instance, in February 2021, Merck & Co. Inc. and Sanofi SA, jointly developed VAXELIS, the first and only hexavalent (six-in-one) combination vaccine available in the US indicated for active immunization to help prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b. VAXELIS is approved for use as a 3-dose series in children of 6 weeks to 4 years of age.

Market Players Outlook

GlaxoSmithKline PLC, Sanofi SA, Pfizer Inc., and Bharat Biotech Ltd., among others, are some of the leading participants in the global DT-based combined vaccines market industry. To increase market share around the world, these companies are using a variety of techniques, including mergers and acquisitions, product launches, geographic expansion and collaboration, and partnership. For instance, in August 2021, Sanofi SA had acquired Translate Bio to accelerate the application of messenger RNA (mRNA) in the development of therapeutics and vaccines. The total transaction value was around $3.2 billion.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global DT-based combined vaccines market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market